tryptamines – mycolab.ai

Norpsilocin: freebase and fumarate salt

mycolabadmin

Researchers determined the crystal structures of norpsilocin, a naturally occurring compound found in magic mushrooms that is chemically similar to psilocin. This work is important because norpsilocin appears to be as potent as psilocin at serotonin receptors and may contribute to the therapeutic effects of magic mushroom extracts. By obtaining pure crystalline forms and understanding the compound’s structure, scientists can better study its properties and potential medical applications for treating conditions like depression and anxiety.

4-Hydroxy-N,N-diisopropyltryptammonium hydrofumarate: Crystal Structure of a Synthetic Psychedelic

mycolabadmin

Scientists have determined the three-dimensional crystal structure of 4-HO-DiPT, a synthetic compound related to psilocin found in magic mushrooms. This is the first crystal structure of this specific compound and provides important structural information for understanding how it works. A related version of this compound is currently being tested in clinical trials for treating postpartum depression and other mood disorders.

A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe

mycolabadmin

Scientists have discovered that magic mushrooms contain compounds called psilocybin and psilocin that show promise in treating depression and other psychiatric conditions. However, extracting enough of these compounds from mushrooms is difficult, so chemists have developed multiple ways to synthesize them in laboratories. This review examines different chemical and biological methods for producing these therapeutic compounds, from traditional synthesis techniques to modern approaches using special catalysts and enzymes, making these medicines more accessible for clinical research.

Bis(4-acetoxy-N-ethyl-N-n-propyltryptammonium) fumarate–fumaric acid (1/1)

mycolabadmin

Researchers determined the precise chemical structure of a synthetic compound related to psilocybin (the active ingredient in psychedelic mushrooms) using X-ray crystallography. The compound, 4-AcO-EPT, is designed to be converted in the body to a psychoactive substance with potential therapeutic benefits for depression and anxiety. The study resolved conflicting reports about the compound’s exact composition and molecular arrangement, showing it exists as a specific combination of three molecular components. This work demonstrates why chemists need to study actual crystal structures rather than relying solely on chemical calculations.

Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids

mycolabadmin

Scientists analyzed 226 mushroom samples from about 30 psychotropic species to measure their psilocybin and related compound content. They found that the amounts of these compounds vary greatly, even within the same species, making it difficult to predict how strong a mushroom will be. The research shows that Psilocybe species generally contain the most psychoactive compounds, with some varieties containing over 15 times more psilocybin than others, highlighting safety concerns for users.

Research Topic: tryptamines

Norpsilocin: freebase and fumarate salt

4-Hydroxy-N,N-diisopropyltryptammonium hydrofumarate: Crystal Structure of a Synthetic Psychedelic

A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe

Bis(4-acetoxy-N-ethyl-N-n-propyltryptammonium) fumarate–fumaric acid (1/1)

Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids